Skip to main content

and
  1. No Access

    Article

    Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy

    The aim of the study was to compare, in a randomized prospective study, the efficacy and safety of intraorbital administration of low doses of RTX versus intravenous glucocorticoids (GCs) to treat patients aff...

    Gustavo Savino, Erika Mandarà, Mariangela Gari, Remo Battendieri in Endocrine (2015)

  2. No Access

    Article

    Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections

    We recently reported on the efficacy of intralesional rituximab for treating primary ocular adnexal lymphoma in a pilot study. After treatment, a complete response was observed in two of five patients, a parti...

    Gustavo Savino, Remo Battendieri in Journal of Cancer Research and Clinical On… (2013)